Current and future modalities for functional renal replacement

practice guidelines: Hemodialysis adequacy, 1997, Peritoneal dialysis adequacy, Am J Kidney Dis, 30, S1 Allison, 1993, Mycopheno-late mofetil (RS-61443): Mechanisms of action and effects in transplantation, Transplant Rev, 7, 129, 10.1016/S0955-470X(05)80012-6 Atala, 1995, Renal cell growth in vivo after attachment to biodegradable polymer scaffolds, J Urol, 153, 4 Bacallao, 1997, Recent advances in the understanding of polycystic kidney disease, Curr Opin Nephrol Hypertens, 6, 377, 10.1097/00041552-199707000-00012 Bailie, 1997, Peritoneal Dialysis Core Indicators Study (PD-CIS): Hematocrit (Hct) and blood pressure (BP) data [abstract], Am Soc J Nephrol, 8, 215a Barber, 1991, Long term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients, Transplantation, 51, 70, 10.1097/00007890-199101000-00011 Bernadini, 1991, An analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD), Clin Nephrol, 36, 29 Bernadini, 1996, A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin, Am J Kidney Dis, 27, 695, 10.1016/S0272-6386(96)90105-5 Bhatala, 1994, Peritoneal access, J Postgrad Med, 40, 170 Bloembergen, 1996, Epidemiological pro-spectives on infections in chronic dialysis patients, Adv Ren Replace Ther, 3, 201, 10.1016/S1073-4449(96)80022-7 Blowey, 1994, The treatment of Staphylococcus aureus nasal carriage in pediatric peritoneal dialysis patients, 297 Bokenkamp, 1995, Improved absorption of cyclosporine A from the microemul-sion formulation: Implications for dosage and monitoring, Pediatr Nephrol, 9, 196, 10.1007/BF00860745 Brauhgler, 1987, Novel 21-aminosteroids as potent inhibitors of iron dependent lipid peroxidation, J Biol Chem, 262, 10438, 10.1016/S0021-9258(18)60979-2 Bruno, 1989, CAPD with amino acid dialysis solution: Long term, cross-over study, Kidney Int, 35, 1189, 10.1038/ki.1989.109 Carley, 1988, Extracellular matrix specificity for the differentiation of capillary endothelial cells, Exp Cell Res, 178, 426, 10.1016/0014-4827(88)90411-9 Chang, 1991, FK-506 and rapa-mycin: Novel pharmacological probes of the immune response, Trends Pharmacol Sci, 12, 218, 10.1016/0165-6147(91)90555-7 Chazan, 1991, The clinical spectrum of renal osteodystrophy in 57 hemodialysis patients: A correlation between biochemical parameters and bone pathology findings, Clin Nephrol, 35, 78 Cho, 1998, Transplantation of kidneys from donors whose hearts have stopped beating, N Engl J Med, 338, 221, 10.1056/NEJM199801223380403 Churchill, 1995, Efficiency and biocompatibility of membranes Cimochowski, 1990, Superiority of the internal jugular over the subclavian access for temporary dialysis, Nephron, 54, 154, 10.1159/000185837 Clark, 1998, Renal replacement therapy in acute renal failure: Solute removal mechanisms and dose quantification, Kidney Int Suppl, 66, S133 Daugirdas, 1985, A double blind evaluation of sodium gradient hemodialysis, Am J Nephrol, 5, 163, 10.1159/000166927 Depner, 1991 Diamond, 1987, Acetate dialysate versus bicarbonate dialysate: A continuing controversy, Am J Kidney Dis, 9, 3, 10.1016/S0272-6386(87)80155-5 Dumler, 1992, Clinical experience with short-time hemodialysis, Am J Kidney Dis, 19, 49, 10.1016/S0272-6386(12)70202-0 Ellis, 1994, Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation, Pediatr Nephrol, 8, 93, 10.1007/BF00865477 Evans, 1998, An economic analysis of kidney transplantation, Surg Clin North Am, 78, 149, 10.1016/S0039-6109(05)70640-X Feldman, 1996, Hemodialysis vascular access morbidity, J Am Soc Nephrol, 7, 523, 10.1681/ASN.V74523 Fischel, 1991, Long-term outlook for transplant recipients with one year function, Transplantation, 51, 118, 10.1097/00007890-199101000-00018 Fishbane, 1996, The evaluation of iron status in hemodialysis patients, J Am Soc Nephrol, 7, 2654, 10.1681/ASN.V7122654 Fishbane, 1997, Iron management in end-stage renal disease, Am J Kidney Dis, 29, 319, 10.1016/S0272-6386(97)90192-X Flanigan, 1997, Dialysate sodium delivery can alter chronic blood pressure management, Am J Kidney Dis, 29, 383, 10.1016/S0272-6386(97)90199-2 Frank, 1993, Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and IL-6 mRNA expression in vitro, Exp Nephrol, 1, 26 Fung, 1996, Reconstitu-tion of poor EGFr-poor renal epithelial cells into tubular structures on biodegradable polymer scaffold, Pediatrics, 98, S631 Gabaw, 1982, The spectrum of rhabdomyolysis, Medicine, 62, 141, 10.1097/00005792-198205000-00002 Gokal, 1996, Peritoneal catheters and exit-site practices: Toward optimum peritoneal access, Perit Dial Int, 13, 29, 10.1177/089686089301300107 Gotch, 1985, A mechanistic analysis o( the National Cooperative Dialysis Study (NCDS), Kidney Int, 28, 526, 10.1038/ki.1985.160 Grinyo, 1995, Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection, Lancet, 345, 1321, 10.1016/S0140-6736(95)92534-1 Grossman, 1974, Nontraumatic acute renal failure, N Engl J Med, 291, 807, 10.1056/NEJM197410172911601 Group, 1992, Canada-USA (CANUSA) multicenter study of peritoneal dialysis adequacy: Description of the study and preliminary results, Adv Perit Dial, 8, 88 Hakim, 1993, Clinical implications of hemodialysis membrane biocompatibility, Kidney Int, 44, 484, 10.1038/ki.1993.272 Hakim, 1994, Effect of dialysis membrane in the treatment of patients with acute renal failure, N Engl J Med, 331, 338, 10.1056/NEJM199411173312003 Hall, 1992, Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord trauma, J Neurotrauma, 9, S425 Health Care Financing Administration, 1997, End stage renal disease program highlights [fact sheet]. Health Care Financing Administration Henrich, 1984, Increased ionized calcium and left ventricular contractility during hemodialysis, N Engl J Med, 310, 19, 10.1056/NEJM198401053100105 Himmelfarb, 1998, A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis, J Am Soc Nephrol, 9, 257, 10.1681/ASN.V92257 Hitchcock, 1964, Baboon renal grafts, JAMA, 189, 934, 10.1001/jama.1964.03070120056013 Humes, 1995, Tissue engineering of a bioartificial hemo-filter [abstract], J Am Soc Nephrol, 6, 492 Ilstad, 1984, Reconstitution with syngenic plus allogenic or xenogenic bone marrow leads to specific acceptance of allografts or xenografts, Nature, 307, 168, 10.1038/307168a0 Jacobs, 1997, Membrane biocompatibility in the treatment of acute renal failure: What is the evidence in 1996, Nephrol Dial Transplant, 12, 38, 10.1093/ndt/12.1.38 Kabasakul, 1997, Comparison of Neoral and Sandimmune cyclosporine A pharmacokinetic profiles in young renal transplant recipients, Pediatr Nephrol, 11, 318, 10.1007/s004670050284 Kasiske, 1998, The evaluation of prospective renal transplant recipients and living donors, Surg Clin North Am, 78, 27, 10.1016/S0039-6109(05)70632-0 Kasiske, 1996, The evaluation of renal transplant candidates: Clinical practice guidelines, J Am Soc Nephrol, 7, 2288, 10.1681/ASN.V7112288 Keane, 1996, Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update, Perit Dial Int, 16, 557, 10.1177/089686089601600606 Kingwatanakul, 1997, Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis, 280 Levin, 1996, The benefits and side effects of hampered hypertonic sodium dialysis, J Am Soc Nephrol, 7, 242, 10.1681/ASN.V72242 Locatelli, 1998, Electrolyte disorders and substitution fluid in continuous renal replacement therapy, Kidney Int Suppl, 66, S151 Luzar, 1990, Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis, N Engl J Med, 322, 505, 10.1056/NEJM199002223220804 Maack, 1992, Renal handling of proteins and polypeptides, 2039 MacKay, 1998, Tissue engineering of a bioartificial kidney, ASAIO J, 44, 179, 10.1097/00002480-199805000-00011 Manns, 1998, Continuous renal replacement therapies: An update, Am J Kidney Dis, 32, 185, 10.1053/ajkd.1998.v32.pm9708602 Mayes, 1988, Re-exposure to OKT3 in renal allograft recipients, Transplantation, 45, 349, 10.1097/00007890-198802000-00021 Mazariegos, 1995, Weaning of immunosuppression in long-term recipients of living related renal transplants: A preliminary study, Transplant Proc, 27, 207 Milici, 1985, The formation of fenestrations and channels by capillary endothelium in vitro, Proc Natl Acad Sei USA, 82, 6181, 10.1073/pnas.82.18.6181 Mistry, 1994, A randomized multicenter clinical trial comparing isosmolar Icodextrin with hyperosmolar glucose solutions in SAPD, Kidney Int, 46, 496, 10.1038/ki.1994.300 Mistry, 1985, The advantage of glucose polymer as an osmotic agent in continuous peritoneal dialysis, Proc EDTA-ERA, 22, 415 Mistry, 1987, Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges, Lancet, 2, 178, 10.1016/S0140-6736(87)90764-1 Morris, 1997, Transplantation in the 21st century, Kidney Int, 51, S51 Mupirocin Study Group, 1996, Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal infection, J Am Soc Nephrol, 7, 2403, 10.1681/ASN.V7112403 Nath, 1995, Heme protein mediated renal injury: A protective role for 21-amino steroids in vitro and in vivo, Kidney Int, 47, 592, 10.1038/ki.1995.75 1997 1993, 1, 11 DOQI-NKF, 1997 DOQI-NKF, 1997 Nolfph, 1969, Mechanisms for inefficient peritoneal dialysis in acute renal failure associated with heat and exercise, Ann Intern Med, 71, 317, 10.7326/0003-4819-71-2-317 Nolph, 1996, Peritoneal dialysis, 281 O'Hair, 1994, Inhibition of chronic vascular rejection in primate cardiac xenografts using mycophenolate mofetil, Ann Thorac Surg, 58, 1311, 10.1016/0003-4975(94)91902-X Odland, 1998, Surgical technique/post-transplant surgical complications, Surg Clin North Am, 78, 55, 10.1016/S0039-6109(05)70634-4 Onishi, 1991, Beta-2-microglobulin deposition in bone in chronic renal failure, Kidney Int, 39, 990, 10.1038/ki.1991.125 Opelz, 1991, Long-term impact of HLA matching on kidney survival in cyclosporine treated patients, Transplant Proc, 23, 373 Owen, 1993, The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis, N Engl J Med, 329, 1001, 10.1056/NEJM199309303291404 Park, 1993, Peritoneal transport during dialysis with amino-acid based solutions, Perit Dial Int, 13, 280, 10.1177/089686089301300404 Pastan, 1998, Dialysis therapy, N Engl J Med, 338, 1428, 10.1056/NEJM199805143382006 Pearson, 1992, Induction of transplantation tolerance in the adult using donor antigen and anti-CD4 monoclonal antibody, Transplantation, 54, 475, 10.1097/00007890-199209000-00018 Perez-Fontan, 1993, Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: Long-term results, Am J Kidney Dis, 22, 708, 10.1016/S0272-6386(12)80434-3 Platt, 1996, Use of transgenic animals in xenotransplantation, Transplant Rev, 10, 69, 10.1016/S0955-470X(96)80013-9 Powelson, 1994, Antilymphocyte globulin and monoclonal antibodies, 215 Princeteau, 1905, Greffe renale, J Med Bordeaux, 26, 549 Program, National Cholesterol Education, Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults, 1993, Summary of the Second Report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel II), JAMA, 269, 3015, 10.1001/jama.269.23.3015 Radovich, 1995, Composition of polymer membranes for therapies of end-stage renal disease, 11 Reemtsma, 1964, Renal heterotransplantation in man, Ann Surg, 160, 384, 10.1097/00000658-196409000-00006 Revillard, 1988, Structure and metabolism of beta-2-microglobulin, Contrib Nephrol, 62, 44, 10.1159/000415474 Rocco, 1996, Utilization of inpatient and outpatient resources for the management of hemodialysis access complications, Am J Kidney Dis, 28, 250, 10.1016/S0272-6386(96)90308-X Rodby, 1994, Blood pressure in hemodialysis and peritoneal dialysis using ambulatory blood pressure monitor, Am J Kidney Dis, 23, 401, 10.1016/S0272-6386(12)81003-1 Saitovitch, 1995, Induction of transplantation tolerance using a non-depleting anti-CD4 monoclonal antibody and donor specific transfusion before transplantation: Evidence that a critical period of time is required for the development of immunological unresponsiveness, Transplant Proc, 27, 117 Salahuden, 1996, Synergistic renal protection by combining alkaline diuresis with lipid peroxidation inhibitors in rhabdomyolysis: Possible interactions between oxidant and non-oxi-dant mechanisms, Nephrol Dial Transplant, 11, 635, 10.1093/oxfordjournals.ndt.a027352 Saran, 1997, Long-term follow-up of kidney donors: A longitudinal study, Nephrol Dial Transplant, 12, 1615, 10.1093/ndt/12.8.1615 Schefer, 1994, Residual renal function in children on hemodialysis and peritoneal dialysis therapy, Pediatr Nephrol, 8, 579, 10.1007/BF00858132 Schnek, 1991, Pediatric renal transplantation under FK-506 immunosuppression, J Urol, 147, 1585, 10.1016/S0022-5347(17)37635-8 Selgas, 1989, Peritoneal functional parameters after five years on continuous ambulatory peritoneal dialysis (CAPD): The effect of late peritonitis, Perit Dial Int, 9, 329, 10.1177/089686088900900421 Sessa, 1997, Autosomal dominant polycystic kidney disease: Clinical and genetic aspects, J Nephrol, 10, 295 Shaffer, 1998, Two hundred one consecutive living-donor nephrectomies, Arch Surg, 133, 426, 10.1001/archsurg.133.4.426 Slater, 1998, Rhabdomyolysis and myoglobinuria renal failure in trauma and surgical patients: A review, J Am Coll Surg, 186, 693, 10.1016/S1072-7515(98)00089-1 Slatopolsky, 1986, Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis, N Engl J Med, 315, 157, 10.1056/NEJM198607173150304 Sollinger, 1995, Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients, Transplantation, 60, 225, 10.1097/00007890-199508000-00003 Stadnyk, 1994, Cytokine production by epithelial cells, FASEB J, 8, 1041, 10.1096/fasebj.8.13.7926369 Starzl, 1992, Cell migration, chimerism and graft acceptance, Lancet, 339, 1579, 10.1016/0140-6736(92)91840-5 Starzl, 1964, Renal heterotransplantation from baboon to man: Experience with 6 cases, Transplantation, 2, 752, 10.1097/00007890-196411000-00009 Stivelman, 1995, Dialysis survival in a large inner-city facility: A comparison to national rates, J Am Soc Nephrol, 6, 1256, 10.1681/ASN.V641256 Sukhatme, 1995, Prospects for gene therapy in the kidney Tearle, 1996, The alpha-l,3-galactosyltransferase knockout mouse: Implications for xenotransplantation, Transplantation, 61, 13, 10.1097/00007890-199601150-00004 Thomas, 1987, Promotion of incompatible allograft acceptance in rhesus monkeys given post-transplant antithymocyte globulin and donor bone marrow. I. In vivo parameters and immunohistologic evidence suggesting mi-crochimerism, Transplantation, 43, 332, 10.1097/00007890-198703000-00002 Twardowski, 1996, Peritoneal catheter exit-site morphology and pathology: Prevention, diagnosis and treatment of exit-site infections, Perit Dial Int, 16, S1 Twardowski, 1996, Four year experience with swan neck presternal peritoneal dialysis catheter, Am J Kidney Dis, 27, 99, 10.1016/S0272-6386(96)90036-0 US Renal Data System, 1996, The USRDS Dialysis Morbidity and Mortality Study (wave 1), 45 United Network for Organ Sharing, 1996, People awaiting transplants 1996 SUSRD, 1997, The USRDS Dialysis Morbidity and Mortality Study: Wave 2, Am J Kidney Dis, 30, 567 USRDS Annual Data Report, 1992, Catheter-related factors and peritonitis risk in CAPD patients, Am J Kidney Dis, 20, 548 Vamvakas, 1998, Cancer in end-stage renal disease: Potential factors involved, Am J Nephrol, 18, 89, 10.1159/000013314 Vilingo, 1989, Prospected randomized study of two Y devices in continuous ambulatory peritoneal dialysis (CAPD), Perit Dial Int, 9, 165, 10.1177/089686088900900305 Warady, 1998, Current advances in the therapy of chronic renal failure and end stage renal disease, Semin Nephrol, 18, 341 Warady, 1995, Optimizing dialysis in pediatric patients, 189 Ward, 1988, Factors predictive of acute renal failure in rhabdomyolysis, Arch Intern Med, 148, 1553, 10.1001/archinte.148.7.1553 Washburn, 1996, Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression, Transplant Proc, 28, 1015 Wilson, 1989, Implantation of vascular grafts lined with genetically modified endothelial cells, Science, 244, 1344, 10.1126/science.2734614 Woods, 1997, Prospects for a bioartificial kidney, Semin Nephrol, 17, 381 Yoo, 1996, Creation of functional kidney structures with excretion of kidney-like fluid in vivo, Pediatrics, 98S, 605 Young, 1989, The use of an amino-acid-based CAPD fluid over 12 weeks, Nephrol Dial Transplant, 4, 285, 10.1093/oxfordjournals.ndt.a091874 Zagler, 1992, Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress: Mechanistic and therapeutic implications, J Clin Invest, 90, 711, 10.1172/JCI115942 Zweibel, 1989, High-level recombinant gene expression in rabbit endothelial cells transduced by retroviral vectors, Science, 243, 220, 10.1126/science.2911735